INS1009-311 PH ILD Pro00119035 A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallelgroup Study to Evaluate the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Insmed
Start Date
February 4, 2026
End Date
September 24, 2030
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Insmed
Start Date
February 4, 2026
End Date
September 24, 2030